Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and r
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and r
![Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences](https://royalsocietypublishing.org/cms/asset/17febebc-6cca-48a7-a0c4-7ca94a27ffbd/373fig2.jpg)
Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences
![Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases | Radiology Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2020200642/asset/images/medium/radiol.2020200642.tbl3.png)
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases | Radiology
![Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ... Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...](https://www.thelancet.com/cms/attachment/4316ed62-4edf-4484-906f-1f26411e627a/gr1_lrg.jpg)
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...
![Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences](https://royalsocietypublishing.org/cms/asset/0cb4869e-768d-4192-a58d-3f32a7ca803c/rstb.360.issue-1454.largecover.jpeg)
Tropical forest cover change in the 1990s and options for future monitoring | Philosophical Transactions of the Royal Society B: Biological Sciences
![Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ... Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...](https://expeditiorepositorio.utadeo.edu.co/bitstream/handle/20.500.12010/14585/Clinical-characteristics-and-outcomes-among-hospitalized-adults-wit_2020_ECl.pdf.jpg?sequence=4&isAllowed=y)
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...
![Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ... Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...](https://ars.els-cdn.com/content/image/1-s2.0-S2589537020303357-gr4.jpg)
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective ...
Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and r
![COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus - hdl:20.500.12010/10692 COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus - hdl:20.500.12010/10692](https://expeditiorepositorio.utadeo.edu.co/bitstream/handle/20.500.12010/10692/COVID-19%20severity%20and%20mortality%20in%20patients%20with%20chronic%20lymphocytic%20leukemia%20a%20joint%20study%20by%20ERIC%2C%20the%20European%20Research%20Initiative%20on%20CLL%2C%20and%20CLL%20Campus.pdf.jpg?sequence=5&isAllowed=y)
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus - hdl:20.500.12010/10692
![Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases | Radiology Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.2020200642/asset/images/medium/radiol.2020200642.fig1.gif)